Sanderling Ventures
Montreal, Quebec, Canada · Seed → Series A
Their stated focus (public profile)
Sanderling Ventures is an early-stage biomedical venture capital firm founded in 1979, dedicated to building new biomedical companies through specialized investment focus and active management. The firm partners closely with entrepreneurs and takes a long-term commitment approach across small molecule therapeutics, biologics, vaccines, drug delivery, platform technologies, and medical devices. Sanderling has supported more than 90 biomedical start-ups and aims to deliver high rates of return for both entrepreneurs and investors.
Stages: Seed → Series A
Sectors: Medtech, Life sciences
On file: 40 companies on record
Website: sanderling.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.